Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for JNJ
142.46
+0.81 (0.57%)
After Hours: 142.46 0.00 (0.00%)
Dec 15, 4:23PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 141.78 - 143.14
52 week 110.76 - 144.35
Open 142.48
Vol / Avg. 12.45M/4.89M
Mkt cap 382.72B
P/E 24.75
Div/yield 0.84/2.36
EPS 5.76
Shares 2.69B
Beta 0.80
Inst. own 68%
Jan 23, 2018
Q4 2017 Johnson & Johnson Earnings Release - 9:30AM EST - Add to calendar
Jan 23, 2018
Q4 2017 Johnson & Johnson Earnings Call - 8:30AM EST - Add to calendar
Dec 14, 2017
Johnson & Johnson at BMO Capital Markets Prescriptions for Success Healthcare Conference - Webcast
Dec 7, 2017
Johnson & Johnson at Citi Global Healthcare Conference - Webcast
Nov 8, 2017
Johnson & Johnson at Credit Suisse Healthcare Conference - Webcast
Oct 17, 2017
Q3 2017 Johnson & Johnson Earnings Release
Oct 17, 2017
Q3 2017 Johnson & Johnson Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '17) 2017
Net profit margin 19.16% 23.01%
Operating margin 24.38% 27.55%
EBITD margin - 35.46%
Return on average assets 9.79% 12.05%
Return on average equity 20.70% 23.37%
Employees 126,400 -
CDP Score - A-

Address

1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ 08933-0001
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Chief Human Resource Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Paulus A. Stoffels Executive Vice President, Chief Scientific Officer
Age: 55
Bio & Compensation  - Reuters
Michael H. Ullmann Executive Vice President, General Counsel
Age: 58
Bio & Compensation  - Reuters
Joaquin Duato Executive Vice President, Worldwide Chairman - Pharmaceuticals
Age: 54
Bio & Compensation  - Reuters
Jorge S. Mesquita Executive Vice President, Worldwide Chairman - Consumer
Age: 55
Bio & Compensation  - Reuters
Sandra E. Peterson Executive Vice President - Group Worldwide Chairman
Age: 58
Bio & Compensation  - Reuters
Joseph Wolk Vice President - Investor Relations
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 64
Bio & Compensation  - Reuters